Compulsive buying — the recurrent, irresistible urge to purchase goods that is disproportionate to need, accompanied by a loss of control, and followed by significant functional consequences — has been recognized as a clinical phenomenon for over a century. Emil Kraepelin described “oniomania” in 1915 as a form of impulsive insanity characterized by an uncontrollable urge to buy. Eugen Bleuler noted it in the same era. Yet despite this early clinical recognition, compulsive buying and spending has never been formally incorporated into any major diagnostic classification system as a named, stand-alone disorder. It is absent from both DSM-5-TR and ICD-11 as a primary diagnostic entity, and the clinical literature that has accumulated around it — substantial in volume if uneven in methodological quality — has developed without the anchor of standardized diagnostic criteria.
This diagnostic absence is not a reflection of clinical insignificance. Estimates of compulsive buying prevalence in the general population of high-income countries range from approximately 5% to 8%, though these figures should be interpreted cautiously given the measurement heterogeneity described later in this series. Financial consequences — debt accumulation, bankruptcy, relationship strain, and occupational impairment — are well documented. Psychological consequences, including shame, concealment, and a characteristic cycle of anticipatory craving, behavioral enactment, and post-purchase regret, are consistently reported across studies and clinical populations. The condition causes genuine harm. The clinical challenge is not establishing that harm exists but characterizing it with sufficient precision to guide assessment, formulation, and intervention.
These modules approach compulsive shopping and spending as a clinically meaningful behavioral pattern whose precise nosological status remains unresolved. Rather than arguing for or against its status as an addiction, an impulse-control disorder, or a manifestation of underlying psychiatric conditions, the analysis maps the behavioral phenomenology, the psychological mechanisms that maintain it, the structural and environmental factors that amplify it, and the practical clinical approaches available in the absence of validated, disorder-specific treatment protocols.
Compulsive buying is best understood as a dimensional phenomenon — occupying a spectrum from normative consumer behavior through dysregulated but non-impairing excess to genuinely disordered engagement — in which functional impairment and loss of control, rather than frequency or expenditure amount, anchor the clinical threshold.